Ashish Kamat speaks with Nimira Alimohamed about the evolution of circulating tumor DNA (ctDNA) in muscle invasive bladder cancer management. Dr. Alimohamed explains that current evidence establishes ctDNA detection as strongly prognostic at multiple timepoints, with detectable ctDNA before neoadjuvant therapy, after neoadjuvant therapy, or post-surgery consistently indicating poor outcomes. She…
Nominate a 2024 STAT Wunderkind STAT Wunderkinds is a chance to celebrate early-career researchers who are not yet independent scientists or program
The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults. The requirements could cost drugmakers…
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Mark Tyson presents a case-based discussion on BCG-unresponsive non-muscle invasive bladder cancer treatment options. He describes a 67-year-old man with recurrent T1 disease after BCG…
At long last, the “one big, beautiful bill” has passed through the House of Representatives, sending an all-encompassing reconciliation package to the Senate. | The…
Across the country, governors continue to make behavioral health a priority—using their State of the State, budget, and inaugural addresses to highlight investments in behavioral…
The emergence of resistance mutations in the SARS-CoV-2 spike (S) protein presents a challenge for monoclonal antibody treatments like sotrovimab. Understanding the structural, dynamics, and…
President Trump claimed his “most favored nation” executive order could cause U.S. drug prices to “drop like a rock” in a matter of weeks
In this interview, Chalmers highlights the implications of his team’s subgroup analysis findings in the ASPEN trial, as well as unmet needs for non-cystic fibrosis…
If you’ve ever had food poisoning caused by Salmonella bacteria, you know it’s unpleasant but typically goes away within two to three days. You may…
